MPM BioVentures 2014 (B), L.P., 10% Owner at Harpoon Therapeutics, Inc. (HARP), sold 23,096 shares at $21.52 ($540K) on 2021-04-12, disclosed to the SEC on 2021-04-13.
Scheduled sale ($540k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.67 | 10,300 | $244K | 45.1% |
| 2 | $23.67 | 10,300 | $244K | 45.1% |
| 3 | $20.72 | 1,637 | $34K | 6.3% |
| 4 | $21.52 | 811 | $17K | 3.2% |
| 5 | $22.68 | 48 | $1K | 0.2% |
| Total | $23.38 avg | 23,096 |
| $540K |
| 100% |